Abiopharma

AIM ImmunoTech Granted U.S. Patent Covering Methods of Manufacturing Therapeutic dsRNA, Including Ampligen®

Organon & Co. - Organon and Evvy Announce Collaboration to Expand Access of XACIATO® (clindamycin phosphate) vaginal gel 2%, a Treatment for Bacterial Vaginosis

Volition Announces MARS Consortium Clinical Study SuggestsNu.Q® H3.1. Concentrations are Closely Associated with Sepsis and Organ Failure

AIM ImmunoTech Granted U.S. Patent Covering Methods of Manufacturing Therapeutic dsRNA, Including Ampligen®

Prenetics Announces First Quarter 2025 Financial Results, Raises FY2025 Outlook, & Crypto Strategy Announcement Soon

Predictive Oncology Develops Functional 3D Organoid Models Exclusively for Labcorp

New Form 144 - RadNet, Inc. Filed: 2025-06-12 AccNo: 0001965301-25-000074 Size: 4 KB

ReShape Lifesciences® Signs Exclusive Distribution Agreement with Recon Supply to Access the VA and DoD Markets

New Form 6-K - ImmunoPrecise Antibodies Ltd. Filed: 2025-06-12 AccNo: 0000950170-25-085146 Size: 53 KB

ReShape Lifesciences® Signs Exclusive Distribution Agreement with Recon Supply to Access the VA and DoD Markets

New Form 8-K - SPRUCE BIOSCIENCES, INC. Filed: 2025-06-12 AccNo: 0000950170-25-085144 Size: 177 KB Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

New Form 4 - Entrada Therapeutics, Inc. Filed: 2025-06-12 AccNo: 0001689375-25-000034 Size: 5 KB

New Form 4 - Entrada Therapeutics, Inc. Filed: 2025-06-12 AccNo: 0001689375-25-000033 Size: 5 KB

New Form 10-Q - enGene Holdings Inc. Filed: 2025-06-12 AccNo: 0000950170-25-085143 Size: 10 MB

New Form 4 - Entrada Therapeutics, Inc. Filed: 2025-06-12 AccNo: 0001689375-25-000032 Size: 5 KB